Literature DB >> 2958361

Absence of risk of human immunodeficiency virus (HIV) infection in recipients of hepatitis B vaccine.

P Amoroso, C Izzo, R Smeraglia, G Lettieri, G Maio, G Flaminio, A Giorgio, P Fico, P Pierri, G Tarro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2958361     DOI： 10.1007/bf00149746

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN： 0393-2990            Impact factor:   8.082


× No keyword cloud information.
  7 in total

1.  Safety of the hepatitis B vaccine.

Authors:  C E Stevens; P E Taylor; P Rubinstein; R C Ting; A J Bodner; M G Sarngadharan; R C Gallo
Journal:  N Engl J Med       Date:  1985-02-07       Impact factor: 91.245

2.  Risk of AIDS in recipients of hepatitis B vaccine.

Authors:  G Papaevangelou; G Kallinikos; A Roumeliotou; K Politou
Journal:  N Engl J Med       Date:  1985-02-07       Impact factor: 91.245

3.  Lack of effect of hepatitis B vaccine on T-cell phenotypes.

Authors:  I M Jacobson; J L Dienstag; R Zachoval; B A Hanrahan; E Watkins; R H Rubin
Journal:  N Engl J Med       Date:  1984-10-18       Impact factor: 91.245

4.  Transfusion-associated acquired immunodeficiency syndrome. Evidence for persistent infection in blood donors.

Authors:  P M Feorino; H W Jaffe; E Palmer; T A Peterman; D P Francis; V S Kalyanaraman; R A Weinstein; R L Stoneburner; W J Alexander; C Raevsky
Journal:  N Engl J Med       Date:  1985-05-16       Impact factor: 91.245

5.  Transmission of HTLV-III infection from human plasma to chimpanzees: an animal model for AIDS.

Authors:  H J Alter; J W Eichberg; H Masur; W C Saxinger; R Gallo; A M Macher; H C Lane; A S Fauci
Journal:  Science       Date:  1984-11-02       Impact factor: 47.728

6.  Acquired immunodeficiency syndrome (AIDS) associated with transfusions.

Authors:  J W Curran; D N Lawrence; H Jaffe; J E Kaplan; L D Zyla; M Chamberland; R Weinstein; K J Lui; L B Schonberger; T J Spira
Journal:  N Engl J Med       Date:  1984-01-12       Impact factor: 91.245

7.  Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.

Authors:  R C Gallo; S Z Salahuddin; M Popovic; G M Shearer; M Kaplan; B F Haynes; T J Palker; R Redfield; J Oleske; B Safai
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.